2. re-examination/re-evaluation Archive (past history)
- Results of Questionnaire Survey on Remote Surveillance (Conformity Assessment of Re-Examination, etc.) (March 2022)
- Explanation of the Revision of Notification Concerning Reexamination, Periodic Safety Reporting and Conformity Surveillance in FY2020 (March 2021)
- Checklist for GPSP Conformity Surveillance of Pharmaceuticals (March 2020)
- Points to keep in mind regarding regulatory amendments for reporting of adverse drug reactions, including periodic reporting (revised version)
Not applicable.